1 |
Executive Summary: Standards of medical care in diabetes--2012. (2011). Diabetes Care, 35(Supplement_1), S4-S10.
|
2 |
Boureau, F., Dubrere, J., & Luu, M. (1990). Study of verbal description in neuropathic pain. Pain, 41, S465.
|
3 |
Dyck, P., Albers, J., Andersen, H., Arezzo, J., Biessels, G., & Bril, V. et al. (2011). Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity. Diabetes/Metabolism Research And Reviews, 27(7), 620-628.
DOI
|
4 |
Feldman, E., Stevens, M., Thomas, P., Brown, M., Canal, N., & Greene, D. (1994). A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care, 17(11), 1281-1289.
DOI
|
5 |
Fullerton, B., Jeitler, K., Seitz, M., Horvath, K., Berghold, A., & Siebenhofer, A. (2014). Intensive glucose control versus conventional glucose control for type 1 diabetes mellitus. Cochrane Database Of Systematic Review, 14(2), CD009122.
|
6 |
Galer, B. & Jensen, M. (1997). Development and preliminary validation of a pain measure specific to neuropathic pain: The Neuropathic Pain Scale. Neurology, 48(2), 332-338.
DOI
|
7 |
Ha, K. & Kim, D. (2015). Trends in the diabetes epidemic in korea. Endocrinol Metab, 30(2), 142. http://dx.doi.org/10.3803/enm.2015.30.2.142
DOI
|
8 |
Lee, S. & Bae, S. (2005). New trend of pain evaluation by brain imaging devices. Science of Emotion and Sensibility, 8(4), 365-374.
|
9 |
Hink, U., Li, H., Mollnau, H., Oelze, M., Matheis, E., & Hartmann, M. et al. (2001). Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circulation Research, 88(2), e14-e22.
DOI
|
10 |
Kwak, Y., Won, R., Lee, H., & Lee, B. (2010). Pain, acupuncture and brain imaging. Science of Emotion and Sensibility, 13(3), 551-558.
|
11 |
Oh, S. (2003). Clinical electromyography. 3rd Ed. Philadelphia: Lippincott Williams & Wilkins. 57-67.
|
12 |
Partanen, J., Niskanen, L., Lehtinen, J., Mervaala, E., Siitonen, O., & Uusitupa, M. (1995). Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus. New England Journal Of Medicine, 333(2), 89-94.
DOI
|
13 |
Won, J. & Park, T. (2016). Recent advances in diagnostic strategies for diabetic peripheral neuropathy. Endocrinol Metab, 31(2), 230.
DOI
|
14 |
Young, M., Boulton, A., Macleod, A., Williams, D., & Sonksen, P. (1993). A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population. Diabetologia, 36(2), 150-154.
DOI
|
15 |
Yang, C., Lin, C., Li, C., Liu, C., Lin, W., & Hwang, K. et al. (2015). Cardiovascular risk factors increase the risks of diabetic peripheral neuropathy in patients with type 2 diabetes mellitus. Medicine, 94(42), e1783.
DOI
|